CB1 Capital Management

Investment ManagementUnited States2-10 Employees

CB1 Capital is an investment manager that specializes in the supply chain of cannabinoid-based wellness solutions, products and therapies that address a wide range of unmet medical conditions, or have commercial use-cases.

The endocannabinoid system (ECS) is the one of the most ubiquitous networks of receptors in the human body and a retrograde signaling system helping to homeostaticly regulate neurotransmission. 

Science is teaching us that by targeting the right receptors with the right cannabinoids, a multitude of wellness indications, applications, and potentially groundbreaking medical breakthroughs are not only plausible—but probable.

We view cannabis through the lens of ten verticals that include biopharmaceuticals, industrial hemp & farming, extraction & nutraceuticals, compliant laboratories, cultivation & dispensaries, cosmetics & vanity, and pet foods & supplements.

CB1 Capital does not touch the plant or move the plant across state lines; we buy, sell, and invest in securities of publicly traded companies only.

This platform was set up to educate and inform; we believe this is the next generation of impact investing and our mission is to effect positive change through cannabinoid wellness.

Integrity matters; CB1 Capital was built with the foundational constructs of honesty, trust and respect and our partners, employees and advisors are held to the highest standard of conduct and operational diligence.

Sign up for free to view info

Email Format Employee directory